---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025884"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2024-07-02T23:59:59+00:00"
generated_at: "2026-05-31T23:45:51.092141+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Processa shareholders elect directors, approve equity plan increase and auditor ratification

## Summary
- All six director nominees (Yorke, Ng, Baluch, Neal, Pannu, Young) elected with over 878K 'For' votes each.
- Amendment to 2019 Omnibus Incentive Plan increasing share pool by 500,000 shares approved (779,164 for, 176,802 against).
- Ratification of BD & Company as independent auditor for 2024 passed with 1,490,908 for, 32,346 against.
- Advisory vote on executive compensation approved with 804,087 for, 164,034 against.

## SEC filing metadata
- accession: 0001493152-24-025884
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2024-07-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315224025884/0001493152-24-025884-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315224025884/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025884
- JSON: https://secwatch.observer/filing/0001493152-24-025884.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025884.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.